The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.

To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation.

The study is designed to assess the safety and efficacy of the Next Generation ICD lead.

PILOT: The study is pilot trial to evaluate the safety and performance of the Twelve TMVR System in very high-risk mitral regurgitation patients.

EFS: The study is an EFS trial to evaluate the safety and performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in patients with severe, symptomatic mitral regurgitation.

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated lipoprotein(a).